I forsøg 3 var ACR20 respons 65% hos patienter behandlet med rituximab alene sammenlignet med 38% med methotrexat alene (p = 0, 025).
In study 3, the ACR20 response in patients treated with rituximab alone was 65% compared with 38% on methotrexate alone (p=0.025).